Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $143,532 - $266,781
-1,135 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $109,974 - $179,464
487 Added 75.15%
1,135 $288,000
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $119,160 - $260,160
-537 Reduced 45.32%
648 $249,000
Q2 2021

Aug 11, 2021

BUY
$129.91 - $234.98 $153,943 - $278,451
1,185 New
1,185 $278,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Equitable Holdings, Inc. Portfolio

Follow Equitable Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Equitable Holdings, Inc. with notifications on news.